NCT Number: NCT06039917
In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus, Quanzhou, Fujian, China
The adherence of doctors to published surveillance guidelines for patients with gastric premalignant lesions varies greatly, and surveillance of patients is critical but time-consuming. In previous studies we developed an automatic surveillance (AS) system to accurately identify patients with gastric premalignant lesions, assign surveillance intervals for different risks of patients and proactively follow up with patients in time. In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An automatic surveillance (AS) system accurately identify patients with gastric premalignant lesions, assign surveillance intervals for different risks of patients and proactively follow up with patients at certain times.
Medical staff remind patients to review manually.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with on-time surveillance, and the denominator is the number of all patients with gastric premalignant lesions requiring surveillance.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with surveillance, and the denominator is the number of all patients with gastric premalignant lesions requiring surveillance.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with surveillance in advance, and the denominator is the number of all patients with gastric premalignant lesions requiring surveillance.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with delayed surveillance, and the denominator is the number of all patients with gastric premalignant lesions requiring surveillance.
Time frame: 1 day At the time of enrollment
The numerator is the number of patients correctly identified by automated surveillance system, and the denominator is the number of all enrolled patients with gastric premalignant lesions.
Time frame: 1 day At the time of enrollment
The numerator is the number of patients correctly classified by automated surveillance system, and the denominator is the number of all enrolled patients with gastric premalignant lesions.
Time frame: 1 day At the time of enrollment
The numerator is the number of patients correctly assigned by automated surveillance system, and the denominator is the number of all enrolled patients with gastric premalignant lesions.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with lesion progression, and the denominator is the number of all patients with gastric premalignant lesions undergoing surveillance.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with lesion persistence, and the denominator is the number of all patients with gastric premalignant lesions undergoing surveillance.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with lesion regression, and the denominator is the number of all patients with gastric premalignant lesions undergoing surveillance.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with early gastric cancer in surveillance endoscopy, and the denominator is the number of all patients with gastric premalignant lesions undergoing surveillance.
Time frame: From enrollment to study completion, assessed up to 3 years.
The numerator is the number of patients with gastric cancer in surveillance endoscopy, and the denominator is the number of all patients with gastric premalignant lesions undergoing surveillance.
Contact information is provided by the study sponsor or research team.
Renmin Hospital of Wuhan University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05894850
Artificial Intelligence, Surveillance
Wuhan, Hubei, China
View Trial DetailsNCT05751824
Artificial Intelligence, Surveillance
Jiangmen, Guangdong, China
View Trial DetailsNCT07721116
Arthritis, Artificial Intelligence
Taipei, Taiwan
View Trial DetailsNCT07515118
Artificial Intelligence, Genital Diseases
Sabadell, Barcelona, Spain
View Trial Details